Literature DB >> 19564635

Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.

Motohito Okabe1, Makoto Otsu, Dong Hyuck Ahn, Toshihiro Kobayashi, Yohei Morita, Yukiko Wakiyama, Masafumi Onodera, Koji Eto, Hideo Ema, Hiromitsu Nakauchi.   

Abstract

Generation of induced pluripotent stem cells (iPSCs) generally uses fibroblastic cells, but other cell sources may prove useful in both research and clinical settings. Although proof of cellular origin requires genetic-marker identification in both target cells and established iPSCs, somatic cells other than mature lymphocytes mostly lack such markers. Here we show definitive proof of direct reprogramming of murine hematopoietic cells with no rearranged genes. Using iPSC factor transduction, we successfully derived iPSCs from bone marrow progenitor cells obtained from a mouse whose hematopoiesis was reconstituted from a single congenic hematopoietic stem cell. Established clones were demonstrated to be genetically identical to the transplanted single hematopoietic stem cell, thus proving their cellular origin. These hematopoietic cell-derived iPSCs showed typical characteristics of iPSCs, including the ability to contribute to chimerism in mice. These results will prompt further use of hematopoietic cells for iPSC generation while enabling definitive studies to test how cellular sources influence characteristics of descendant iPSCs.

Entities:  

Mesh:

Year:  2009        PMID: 19564635     DOI: 10.1182/blood-2009-02-203695

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.

Authors:  Xiaohu Ge; I-Ning E Wang; Ildiko Toma; Vittorio Sebastiano; Jianwei Liu; Manish J Butte; Renee A Reijo Pera; Phillip C Yang
Journal:  Stem Cells Dev       Date:  2012-06-11       Impact factor: 3.272

Review 2.  Advances in cellular technology in the hematology field: What have we learned so far?

Authors:  Gustavo Torres de Souza; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Danielle Luciana Aurora Soares do Amaral; Francisco Carlos da Guia; Rafaella de Souza Salomão Zanette; João Vitor Paes Rettore; Natana Chaves Rabelo; Lucas Mendes Nascimento; Ícaro França Navarro Pinto; Júlia Boechat Farani; Abrahão Elias Hallack Neto; Fernando de Sá Silva; Carlos Magno da Costa Maranduba; Angelo Atalla
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

3.  Reprogramming of T cells from human peripheral blood.

Authors:  Yuin-Han Loh; Odelya Hartung; Hu Li; Chunguang Guo; Julie M Sahalie; Philip D Manos; Achia Urbach; Garrett C Heffner; Marica Grskovic; Francois Vigneault; M William Lensch; In-Hyun Park; Suneet Agarwal; George M Church; James J Collins; Stefan Irion; George Q Daley
Journal:  Cell Stem Cell       Date:  2010-07-02       Impact factor: 24.633

Review 4.  Stem cell therapy: an exercise in patience and prudence.

Authors:  Huan-Ting Lin; Makoto Otsu; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 5.  Generation of iPS cells from normal and malignant hematopoietic cells.

Authors:  Keiki Kumano; Shunya Arai; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-06-27       Impact factor: 2.490

6.  Comparing the reprogramming efficiency of mouse embryonic fibroblasts, mouse bone marrow mesenchymal stem cells and bone marrow mononuclear cells to iPSCs.

Authors:  Lei Wang; Mingyan Zhu; Qingsong Guo; Xiangjun Fan; Yuhua Lu; Shajun Zhu; Yao Wang; Yan Huang; Zhiwei Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-03-29       Impact factor: 2.416

7.  Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.

Authors:  Amal Kambal; Gaela Mitchell; Whitney Cary; William Gruenloh; Yunjoon Jung; Stefanos Kalomoiris; Catherine Nacey; Jeannine McGee; Matt Lindsey; Brian Fury; Gerhard Bauer; Jan A Nolta; Joseph S Anderson
Journal:  Mol Ther       Date:  2010-11-30       Impact factor: 11.454

8.  Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.

Authors:  Yohei Hayashi; Techuan Chan; Masaki Warashina; Masakazu Fukuda; Takashi Ariizumi; Koji Okabayashi; Naoya Takayama; Makoto Otsu; Koji Eto; Miho Kusuda Furue; Tatsuo Michiue; Kiyoshi Ohnuma; Hiromitsu Nakauchi; Makoto Asashima
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

9.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Authors:  Zhaohui Ye; Huichun Zhan; Prashant Mali; Sarah Dowey; Donna M Williams; Yoon-Young Jang; Chi V Dang; Jerry L Spivak; Alison R Moliterno; Linzhao Cheng
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

10.  Highly efficient reprogramming and characterization of induced pluripotent stem cells by using a microwell array.

Authors:  Hyun Lee; Gyu Man Kim; Jin Ho Choi; Min Hee Park; Jae-Sung Bae; Hee Kyung Jin
Journal:  Tissue Eng Regen Med       Date:  2016-12-17       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.